United States v. Fidalgis Font
Marc Seitles represented Fidalgis Font, CEO of Tellus Clinical Research, in a federal healthcare fraud case alleging “fake” clinical drug trials. Font was acquitted of conspiracy, wire fraud, mail fraud, and money laundering charges. The matter received coverage from Law360 and the Miami Herald.
Related victory: United States vs Fidalgis Font
Media coverage:
- Law360 — Jury Clears Miami Drug Trial Co.’s CEO Of Fraud Charges (05/19/2023)
- Miami Herald — Miami prosecutors lose medical fraud case alleging ring ran ‘fake’ clinical drug trials (05/19/2023)
United States v. Justin Magnuson
After challenging the government’s drug-trafficking and money-laundering theory, Marc Seitles helped resolve Justin Magnuson’s federal indictment with a favorable outcome. Coverage also followed Magnuson’s later justice-reform advocacy.
Related victory: United States v. Justin Magnuson
Media coverage:
Healthcare Fraud, Money Laundering & Complex Federal Investigations
Marc Seitles is frequently quoted as counsel in Miami Herald and other coverage of healthcare fraud, money-laundering, and related federal enforcement matters.
Media coverage:
- Miami Herald — Miami federal judge accuses prosecutors of spying on defense, orders new trial (12/22/2022)
- Miami Herald — Judge throws out major sweepstakes fraud case, orders new trial
- Miami Herald — Once imprisoned for Medicare fraud, Miami operator charged again in big case linked to Cuba (08/02/2019)
- Miami Herald — Miami man arrested in $230 million HIV-drug scheme, then gains release from fed lockup (07/05/2022)
- Miami Herald — Federal agent charged with tipping off target of healthcare fraud investigation in Miami (07/22/2020)
- Sun Sentinel — Massive $23 million auto insurance fraud was an intricate operation (10/14/2017)